<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
LOTUSEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lotus Eye Hospital has filed its mandatory annual disclosure required by SEBI for companies classified as 'Large Corporates.' The report covers the 2-year block period of FY 2024-25 and FY 2025-26. All key fields related to incremental borrowing, mandatory borrowing through debt securities, actual borrowing done, and any shortfall in borrowing have been reported as 'NA' (not applicable). Similarly, the section on penalty details for the previous block also shows 'NA.' This indicates the company either has no qualifying borrowing through debt securities or the SEBI large corporate borrowing thresholds do not trigger any mandatory requirements for it in this block period.
This is a routine regulatory compliance filing with no material financial impact. Shareholders are not affected as there are no new borrowings, shortfalls, or penalties disclosed.